Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harvey Alter

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Virology|March 27, 2009
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivityZhen-yong Keck, Sophia H Li, Jinming Xia, et al.
Journal of Translational Medicine|February 2, 2010
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapyVladia Monsurrò, Stefania Beghelli, Richard Wang, et al.
Journal of Virology|May 17, 2013
HIV populations are large and accumulate high genetic diversity in a nonlinear fashionFrank Maldarelli, Mary Kearney, Sarah Palmer, et al.
The Journal of Clinical Investigation|April 3, 2014
Melanoma NOS1 expression promotes dysfunctional IFN signalingQiuzhen Liu, Sara Tomei, Maria Libera Ascierto, et al.
Antiviral Research|December 18, 2017
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshopTimothy M Block, Harvey Alter, Nathaniel Brown, et al.
Hepatology (Baltimore, Md.)|September 7, 2017
A research agenda for curing chronic hepatitis B virus infectionHarvey Alter, Timothy Block, Nathaniel Brown, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Virology|March 27, 2009
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivityZhen-yong Keck, Sophia H Li, Jinming Xia, et al.
Journal of Translational Medicine|February 2, 2010
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapyVladia Monsurrò, Stefania Beghelli, Richard Wang, et al.
Journal of Virology|May 17, 2013
HIV populations are large and accumulate high genetic diversity in a nonlinear fashionFrank Maldarelli, Mary Kearney, Sarah Palmer, et al.
The Journal of Clinical Investigation|April 3, 2014
Melanoma NOS1 expression promotes dysfunctional IFN signalingQiuzhen Liu, Sara Tomei, Maria Libera Ascierto, et al.
Antiviral Research|December 18, 2017
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshopTimothy M Block, Harvey Alter, Nathaniel Brown, et al.
Hepatology (Baltimore, Md.)|September 7, 2017
A research agenda for curing chronic hepatitis B virus infectionHarvey Alter, Timothy Block, Nathaniel Brown, et al.
Pageof 3